Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 2001, p. 3270-3272, Vol. 45, No. 11
Division of Respiratory Diseases, Department
of Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki
City, Okayama 701-0192, Japan
Received 13 July 2000/Returned for modification 6 December
2000/Accepted 23 July 2001
The in vitro and in vivo antichlamydial activity of sitafloxacin
was investigated. The MICs and minimal chlamydiacidal concentrations of
sitafloxacin for various species of chlamydia ranged from 0.031 to
0.125 µg/ml. Sitafloxacin had an excellent therapeutic effect on
experimental Chlamydia psittaci pneumonia and was more
potent than tosufloxacin, ofloxacin, and ciproflxacin, although
slightly less potent than sparfloxacin.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.11.3270-3272.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
In Vitro and In Vivo Activities of Sitafloxacin against
Chlamydia spp.
*
Corresponding author. Mailing address: Division of
Respiratory Diseases, Department of Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama 701-0192, Japan. Phone: 81-86-462-1111. Fax: 81-86-463-6510. E-mail:
nao{at}med.kawasaki-m.ac.jp.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»